Claire Corcoran

3.6k citations

24 papers · 2.4k indexed · 2 hit papers · h-index 17

Molecular Biology top 5%
Cancer Research top 1%
Pulmonary and Respiratory Medicine top 5%
Oncology top 5%
Epidemiology

Co-authors: Lorraine O’Driscoll Sweta Rani John Crown Keith O’Brien Anne M. Friel Marek W. Radomski Amanda O’Neill Maria Prencipe
Topics: Extracellular vesicles in disease (7 papers)Prostate Cancer Treatment and Research (7 papers)MicroRNA in disease regulation (6 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: New England Journal of Medicine Nucleic Acids Research Journal of Clinical Oncology
Partner nations: Ireland United States United Kingdom

In The Last Decade

Claire Corcoran

23 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

2020 474 citations Maha Hussain, Joaquı́n Mateo et al. New England Journal of Medicine profile →
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

2012 377 citations Claire Corcoran, Sweta Rani et al. PLoS ONE profile →

Peers

Countries citing papers authored by Claire Corcoran

Since Specialization

Citations

This map shows the geographic impact of Claire Corcoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Corcoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Corcoran more than expected).

Fields of papers citing papers by Claire Corcoran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Corcoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Corcoran. The network helps show where Claire Corcoran may publish in the future.

Co-authorship network of co-authors of Claire Corcoran

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Corcoran. A scholar is included among the top collaborators of Claire Corcoran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Corcoran. Claire Corcoran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis and biological evaluation of a novel bioactive indane scaffold 2-(diphenylmethylene)c-2,3-dihydro-1H-inden-1-one with potential anticancer activity 2023 ·European Journal of Pharmaceutical Sciences ·Tao Zhang,(unknown),Claire Corcoran,Ismael Obaidi,Manuel Ruether,John E. O’Brien,Lorraine O’Driscoll,Neil Frankish,Helen Sheridan	6
2	Detection of BRCA1 , BRCA2 , and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound 2022 ·Clinical Cancer Research ·Kim N.,Alan Barnicle,(unknown),Zhongwu Lai,Claire Corcoran,J. Carl Barrett,Carrie A. Adelman,Ping Qiu,Ashley Easter,Simon Dearden,Geoffrey R. Oxnard,Neeraj Agarwal,Arun Azad,Johann S. de Bono,Joaquı́n Mateo,David Olmos,Antoine Thiery-Vuillemin,Elizabeth A. Harrington	46
3	Concordance of BRCA1, BRCA2 (BRCA), and ATM mutations identified in matched tumor tissue and circulating tumor DNA (ctDNA) in men with metastatic castration-resistant prostate cancer (mCRPC) screened in the PROfound study. 2021 ·Journal of Clinical Oncology ·Kim N.,Alan Barnicle,(unknown),Zhongwu Lai,Claire Corcoran,(unknown),J. Carl Barrett,Carrie A. Adelman,Ping Qiu,Ashley Easter,Simon Dearden,Elizabeth A. Harrington	22
4	Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancerbreakdown → 2020 ·New England Journal of Medicine ·Maha Hussain,Joaquı́n Mateo,Karim Fizazi,Fred Saad,Neal D. Shore,Shahneen Sandhu,Kim N.,Oliver Sartor,Neeraj Agarwal,David Olmos,Antoine Thiery-Vuillemin,Przemyslaw Twardowski,Guilhem Roubaud,Mustafa Özgüroğlu,Jinyu Kang,Joseph E. Burgents,Christopher Gresty,Claire Corcoran,Carrie A. Adelman,Johann S. de Bono	474
5	610O Final overall survival (OS) analysis of PROfound: Olaparib vs physician’s choice of enzalutamide or abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations 2020 ·Annals of Oncology ·Johann S. de Bono,Joaquı́n Mateo,Karim Fizazi,Fred Saad,Neal D. Shore,Shahneen Sandhu,K.N. Chi,Oliver Sartor,Neeraj Agarwal,David Olmos,Antoine Thiery-Vuillemin,P. Twardowski,Guilhem Roubaud,Mustafa Özgüroğlu,Jinyu Kang,Joseph E. Burgents,Christopher Gresty,Claire Corcoran,Carrie A. Adelman,Maha Hussain	7
6	Next-generation sequencing (NGS) of tumor tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC): The PROfound phase III study experience. 2020 ·Journal of Clinical Oncology ·Maha Hussain,Joaquı́n Mateo,Shahneen Sandhu,Karim Fizazi,Fred Saad,Neal D. Shore,David Olmos,Claire Corcoran,(unknown),Alexander Kohlmann,Carrie A. Adelman,Julia A. Elvin,Carsten Goessl,Joseph E. Burgents,Johann S. de Bono	10
7	Central, prospective detection of homologous recombination repair gene mutations (HRRm) in tumour tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC) screened for the PROfound study 2019 ·Annals of Oncology ·Johann S. de Bono,Karim Fizazi,Fred Saad,Neal D. Shore,Shahneen Sandhu,Niven Mehra,Michael Kolinsky,Guilhem Roubaud,Mustafa Özgüroğlu,Nobuaki Matsubara,Craig Gedye,Young Deuk Choi,(unknown),Carsten Goessl,Alexander Kohlmann,Claire Corcoran,Carrie A. Adelman,A. Allen,Joseph E. Burgents,Maha Hussain	32
8	Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients 2017 ·PLoS ONE ·Elza C. de Bruin,(unknown),Claire Corcoran,(unknown),Jayne C. Fox,Javier Armisen,Justin P.O. Lindemann,Gaia Schiavon,Helen J. Ambrose,Alexander Kohlmann	9
9	Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC) 2016 ·PLoS ONE ·James Sherwood,Claire Corcoran,Helen Brown,Alan Sharpe,(unknown),Alexander Kohlmann	122
10	miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity 2015 ·Oncotarget ·Keith O’Brien,Michelle C. Lowry,Claire Corcoran,Vanesa G. Martínez,(unknown),Sweta Rani,William M. Gallagher,Marek W. Radomski,Roderick A.F. MacLeod,Lorraine O’Driscoll	213
11	miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer 2014 ·Molecular Cancer ·Claire Corcoran,Sweta Rani,Susan Breslin,Martina Gogarty,Irene M. Ghobrial,John Crown,Lorraine O’Driscoll	67
12	Receptor Tyrosine Kinases and Drug Resistance: Development and Characterization of In Vitro Models of Resistance to RTK Inhibitors 2014 ·Methods in molecular biology ·Claire Corcoran,Lorraine O’Driscoll	9
13	Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors 2014 ·Cancer Research ·Sweta Rani,Claire Corcoran,(unknown),Serena Germano,Susan Breslin,Stephen F. Madden,Martina S.J. McDermott,Brigid C. Browne,Norma O’Donovan,John Crown,Martina Gogarty,Annette T. Byrne,Lorraine O’Driscoll	39
14	Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells 2013 ·European Journal of Cancer ·Keith O’Brien,Sweta Rani,Claire Corcoran,Robert G. Wallace,Linda Hughes,Anne M. Friel,Susan McDonnell,John Crown,Marek W. Radomski,Lorraine O’Driscoll	191
15	Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomesbreakdown → 2012 ·PLoS ONE ·Claire Corcoran,Sweta Rani,Keith O’Brien,Amanda O’Neill,Maria Prencipe,(unknown),Glenn F. Webb,Ray McDermott,William Watson,John Crown,Lorraine O’Driscoll	377
16	Characterisation and manipulation of docetaxel resistant prostate cancer cell lines 2011 ·Molecular Cancer ·Amanda O’Neill,Maria Prencipe,Catherine Dowling,Yue Fan,Laoighse Mulrane,William M. Gallagher,Darran P. O’Connor,Robert O’Connor,Aoife Devery,Claire Corcoran,Sweta Rani,Lorraine O’Driscoll,John M. Fitzpatrick,R. William G. Watson	174
17	Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling 2011 ·Methods in molecular biology ·Sweta Rani,Keith O’Brien,Fergal C. Kelleher,Claire Corcoran,Serena Germano,Marek W. Radomski,John Crown,Lorraine O’Driscoll	93
18	Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer 2010 ·Breast Cancer Research and Treatment ·Anne M. Friel,Claire Corcoran,John Crown,Lorraine O’Driscoll	55
19	Bacterial DNA topology and infectious disease 2008 ·Nucleic Acids Research ·Charles J. Dorman,Claire Corcoran	57
20	Isolated Antibody to Hepatitis B Core Antigen in Human Immunodeficiency Virus Type-1--Infected Individuals 2003 ·Clinical Infectious Diseases ·Rajesh T. Gandhi,Alysse G. Wurcel,Hwankyu Lee,Barbara McGovern,(unknown),Robert D. Gerwin,Claire Corcoran,Zbigniew M. Szczepiorkowski,(unknown),Daniel E. Cohen,Paul E. Sax,Chinweike Ukomadu	75

About Claire Corcoran

Claire Corcoran is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 2.4k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), Prostate Cancer Treatment and Research (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (1.7k citations) and Oncology (662 citations). Claire Corcoran has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Lorraine O’Driscoll, Sweta Rani, John Crown, Keith O’Brien, Anne M. Friel, Marek W. Radomski, Amanda O’Neill, Maria Prencipe, Michael J. Duffy and William M. Gallagher. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact